Optometrists in Whitesburg, KY Accepting Medicare

7 Optometrists found. Showing 1 - 7

Debbie Kaye Williams, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 19 Solomon Rd, Whitesburg, KY 41858 Phone: 606-633-4481    Fax: 606-633-0207

Eye Care Cntr Optometrist Medicare: Medicare Enrolled Practice Location: 29 Maple St, Whitesburg, KY 41858 Phone: 606-633-5200    Fax: 606-633-1500

David Shane Barker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 226 Medical Plaza Ln, Whitesburg, KY 41858 Phone: 606-633-4871

Timothy Finn, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 226 Medical Plaza Ln, Whitesburg, KY 41858 Phone: 606-633-4871    Fax: 606-633-0883

D K Williams Psc Optometrist Medicare: Medicare Enrolled Practice Location: 19 Solomon Rd, Whitesburg, KY 41858 Phone: 606-633-4481    Fax: 606-633-0207

Dr. Kelley Bentley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 19 Solomon Rd, Whitesburg, KY 41858 Phone: 606-633-4481

Natasha Nicole Gay, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 226 Medical Plaza Ln, Whitesburg, KY 41858 Phone: 606-633-4871

News Archive

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.

Methodology and evidence behind national mammography guidelines is questionable, says JDMS review

The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a review in the Journal of Diagnostic Medical Sonography (JDMS), published by SAGE.

Russian Ministry of Health approves Medivir's simeprevir for chronic hepatitis C genotype 1 infection

Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.

Survey reveals drug and alcohol abuse in British teens

According to a government survey in the UK almost half of all youngsters between the age of 10 and 15 say they have consumed alcohol. This survey on the lifestyles and concerns of children has revealed startling drug and alcohol abuse problems.

Biomoda submits new U.S. Patent application for CyPath lung cancer assay

Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.

Read more Medical News

› Verified 4 days ago